[Event Report] The Fourth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) (December 14, 2020)
date : 2/19/2021
Tags: AMR
![[Event Report] The Fourth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) (December 14, 2020)](https://hgpi.org/en/wp-content/uploads/sites/2/AMRalliance-logo-11-4.jpg)
AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) held The Fourth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC).
At this fourth meeting, participants from the public and private sectors discussed ways to advocate for our recommendations on the creation of a sustainable research and development (R&D) environment for antimicrobials in Japan.
In light of the situation with novel coronavirus, this meeting was carried out primarily online. On-site participants were encouraged to keep a safe physical distance from each other.
■Overview
Date and time: Monday, December 14, 2020
Organizer: AMR Alliance Japan (Secretariat: Health and Global Policy Institute)
■Program
Greetings and Opening Remarks
Kazuhiro Tateda (President, The Japanese Association for Infectious Diseases / President, The Japanese Society for Clinical Microbiology / Professor, Department of Microbiology and Infectious Diseases, Toho University)
Ryoji Noritake (CEO, Board Member, Health and Global Policy Institute (AMR Alliance Japan Secretariat))
Report on The 7th NIKKEI FT Communicable Diseases Conference and Advocacy Plan Proposed by the Secretariat:
Matt McEnany (AMR Alliance Japan Secretariat/Senior Manager, Health and Global Policy Institute)
Discussion
Chair:
Kazuhiro Tateda (President, The Japanese Association for Infectious Diseases / President, The Japanese Society for Clinical Microbiology / Professor, Department of Microbiology and Infectious Diseases, Toho University)
• Advocacy Plan
• Timelines
• Target groups
Facilitator:
Yui Kohno (AMR Alliance Japan Secretariat/Associate, Health and Global Policy Institute)
Closing Remarks:
Mitsuru Miyata (Representative Director, Healthcare Innovation Co.,Ltd./ Representative Director, Miyata Research Institute Co., Ltd.)
■Related events held as part of the “The Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)” project in and after FY2019 (chronological order)
January 22, 2020 The First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
September 23, 2020 The Third Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
November 7, 2020 The 7th NIKKEI FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC)
Top Research & Recommendations Posts
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Strengthening Lifelong Mental Health Support for Children with Intellectual Disabilities (April 30, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Event Report] Round Table Discussion “Understanding Menopausal Women’s Health as a Social Issue” (Preliminary Version) (November 19, 2024)
- [Recommendations] HGPI Expert Policy Advocacy Platform “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 7, 2025)
Featured Posts
-
2025-04-17
[Registration Open] (Webinar) The 134th HGPI Seminar “Understanding Evidence-Based Dietary Guidelines: Leveraging the Dietary Reference Intakes for Japanese” (May 28, 2025)
-
2025-04-23
[Registration Open] Recruitment of the Health Policy Academy the 14th Session (Starts July 2025)
-
2025-05-02
[Registration Open] (Webinar) The 133rd HGPI Seminar -HGPI Expert Policy Advocacy Platform- “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 20, 2025)
-
2025-05-07
[Recommendations] HGPI Expert Policy Advocacy Platform “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 7, 2025)
-
2025-05-07
[Registration Open] Japan-Australia Online Round Table Discussion “The Impact of Social Media on the Mental Health of Children and Young People and How Social Media Should Be Used in Society“ (May 23, 2025)